sn
int64 | material
string | shape
string | coat_functional_group
string | synthesis_method
string | surface_charge
string | size_in_medium_nm
float64 | zeta_in_medium_mv
float64 | no_of_cells_cells_well
float64 | human_animal
string | cell_source
string | cell_tissue
string | cell_morphology
string | cell_age
string | time_hr
int64 | concentration
float64 | test
string | test_indicator
string | viability_%
float64 | doi
string | article_list
int64 | core_nm
float64 | hydrodynamic_nm
float64 | potential_mv
float64 | cell_type
string | journal_name
string | publisher
string | year
int64 | title
string | journal_is_oa
bool | is_oa
string | oa_status
string | pdf
string | access
int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,530 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 24 | 25 |
CellTiterGlo
|
LuciferaseEnzyme
| 78.385 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,531 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 24 | 50 |
CellTiterGlo
|
LuciferaseEnzyme
| 64.371 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,532 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 24 | 100 |
CellTiterGlo
|
LuciferaseEnzyme
| 47.506 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,533 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 24 | 200 |
CellTiterGlo
|
LuciferaseEnzyme
| 34.204 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,534 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 24 | 400 |
CellTiterGlo
|
LuciferaseEnzyme
| 19.002 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,535 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 48 | 25 |
CellTiterGlo
|
LuciferaseEnzyme
| 65.321 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,536 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 48 | 50 |
CellTiterGlo
|
LuciferaseEnzyme
| 50.356 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,537 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 48 | 100 |
CellTiterGlo
|
LuciferaseEnzyme
| 37.53 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,538 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 48 | 200 |
CellTiterGlo
|
LuciferaseEnzyme
| 26.128 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,539 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 48 | 400 |
CellTiterGlo
|
LuciferaseEnzyme
| 16.865 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,540 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 72 | 25 |
CellTiterGlo
|
LuciferaseEnzyme
| 44.893 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,541 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 72 | 50 |
CellTiterGlo
|
LuciferaseEnzyme
| 34.204 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,542 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 72 | 100 |
CellTiterGlo
|
LuciferaseEnzyme
| 24.466 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,543 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 72 | 200 |
CellTiterGlo
|
LuciferaseEnzyme
| 16.39 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,544 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Breast
|
Epithelial
|
Adult
| 72 | 400 |
CellTiterGlo
|
LuciferaseEnzyme
| 11.164 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
MCF-7
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,545 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 24 | 25 |
CellTiterGlo
|
LuciferaseEnzyme
| 79.426 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,546 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 24 | 50 |
CellTiterGlo
|
LuciferaseEnzyme
| 59.809 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,547 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 24 | 100 |
CellTiterGlo
|
LuciferaseEnzyme
| 50.239 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,548 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 24 | 200 |
CellTiterGlo
|
LuciferaseEnzyme
| 33.971 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,549 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 24 | 400 |
CellTiterGlo
|
LuciferaseEnzyme
| 19.856 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,550 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 48 | 25 |
CellTiterGlo
|
LuciferaseEnzyme
| 59.809 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,551 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 48 | 50 |
CellTiterGlo
|
LuciferaseEnzyme
| 48.086 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,552 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 48 | 100 |
CellTiterGlo
|
LuciferaseEnzyme
| 39.234 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,553 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 48 | 200 |
CellTiterGlo
|
LuciferaseEnzyme
| 29.665 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,554 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 48 | 400 |
CellTiterGlo
|
LuciferaseEnzyme
| 16.029 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,555 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 72 | 25 |
CellTiterGlo
|
LuciferaseEnzyme
| 45.215 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,556 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 72 | 50 |
CellTiterGlo
|
LuciferaseEnzyme
| 38.278 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,557 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 72 | 100 |
CellTiterGlo
|
LuciferaseEnzyme
| 29.665 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,558 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 72 | 200 |
CellTiterGlo
|
LuciferaseEnzyme
| 23.206 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,559 |
Pt
|
Sphere
|
FA
|
Chemical Reduction
|
Negative
| null | null | 5,000 |
H
|
Human
|
Lung
|
Fibroblast
|
Adult
| 72 | 400 |
CellTiterGlo
|
LuciferaseEnzyme
| 14.593 |
10.1039/c0nr00204f
| 80 | null | 12.5 | -40.5 |
IMR90
|
Nanoscale
|
Royal Society of Chemistry (RSC)
| 2,010 |
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles
| false |
FALSE
|
closed
|
80_teow2010.pdf
| 0 |
2,560 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 3.125 |
MTS
|
TetrazoliumSalt
| 98.282 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,561 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 6.25 |
MTS
|
TetrazoliumSalt
| 82.646 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,562 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 12.5 |
MTS
|
TetrazoliumSalt
| 15.636 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,563 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 25 |
MTS
|
TetrazoliumSalt
| 5.4983 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,564 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 50 |
MTS
|
TetrazoliumSalt
| 2.921 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,565 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 100 |
MTS
|
TetrazoliumSalt
| 1.2027 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,566 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 3.125 |
MTS
|
TetrazoliumSalt
| 100.86 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,567 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 6.25 |
MTS
|
TetrazoliumSalt
| 101.89 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,568 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 12.5 |
MTS
|
TetrazoliumSalt
| 103.78 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,569 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 25 |
MTS
|
TetrazoliumSalt
| 101.2 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,570 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 50 |
MTS
|
TetrazoliumSalt
| 83.333 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,571 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 100 |
MTS
|
TetrazoliumSalt
| 56.701 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,572 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 3.125 |
MTS
|
TetrazoliumSalt
| 97.595 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,573 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 6.25 |
MTS
|
TetrazoliumSalt
| 97.079 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,574 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 12.5 |
MTS
|
TetrazoliumSalt
| 103.26 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,575 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 25 |
MTS
|
TetrazoliumSalt
| 107.73 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,576 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 50 |
MTS
|
TetrazoliumSalt
| 88.144 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,577 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
A
|
Mouse
|
Ascites
|
Monocyte/Macrophage
|
Adult
| 48 | 100 |
MTS
|
TetrazoliumSalt
| 73.196 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
RAW264.7
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,578 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 3.125 |
MTS
|
TetrazoliumSalt
| 70.872 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,579 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 6.25 |
MTS
|
TetrazoliumSalt
| 8.9054 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,580 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 12.5 |
MTS
|
TetrazoliumSalt
| 7.0501 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,581 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 25 |
MTS
|
TetrazoliumSalt
| 3.525 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,582 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 50 |
MTS
|
TetrazoliumSalt
| 2.7829 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,583 |
Fe3O4
|
Sphere
|
PEI
|
Commercial
|
Positive
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 100 |
MTS
|
TetrazoliumSalt
| 1.4842 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | 29.28 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,584 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 3.125 |
MTS
|
TetrazoliumSalt
| 101.11 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,585 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 6.25 |
MTS
|
TetrazoliumSalt
| 102.23 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,586 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 12.5 |
MTS
|
TetrazoliumSalt
| 105.38 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,587 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 25 |
MTS
|
TetrazoliumSalt
| 91.466 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,588 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 50 |
MTS
|
TetrazoliumSalt
| 77.922 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,589 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 100 |
MTS
|
TetrazoliumSalt
| 56.215 |
10.1038/s41598-018-19628-z
| 81 | null | 10 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,590 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 3.125 |
MTS
|
TetrazoliumSalt
| 98.33 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,591 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 6.25 |
MTS
|
TetrazoliumSalt
| 99.629 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,592 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 12.5 |
MTS
|
TetrazoliumSalt
| 100 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,593 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 25 |
MTS
|
TetrazoliumSalt
| 98.887 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,594 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 50 |
MTS
|
TetrazoliumSalt
| 82.56 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,595 |
Fe3O4
|
Sphere
|
PEG
|
Commercial
|
Neutral
| null | null | null |
H
|
Human
|
Ovary
|
Epithelial
|
Adult
| 48 | 100 |
MTS
|
TetrazoliumSalt
| 66.605 |
10.1038/s41598-018-19628-z
| 81 | null | 30 | -0.52 |
SKOV-3
|
Scientific Reports
|
Springer Science and Business Media LLC
| 2,018 |
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
| true |
TRUE
|
gold
|
81_feng2018.pdf
| 1 |
2,596 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.001 |
MTT
|
TetrazoliumSalt
| 97.03 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,597 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.01 |
MTT
|
TetrazoliumSalt
| 100 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,598 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.1 |
MTT
|
TetrazoliumSalt
| 100 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,599 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 1 |
MTT
|
TetrazoliumSalt
| 97.03 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,600 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 5 |
MTT
|
TetrazoliumSalt
| 93.399 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,601 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 10 |
MTT
|
TetrazoliumSalt
| 93.399 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,602 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 20 |
MTT
|
TetrazoliumSalt
| 92.739 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,603 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 50 |
MTT
|
TetrazoliumSalt
| 86.799 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,604 |
MgO
|
Sphere
| null |
Commercial
|
Positive
| 639 | 11.6 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 100 |
MTT
|
TetrazoliumSalt
| 73.597 |
10.1007/s10565-011-9191-9
| 82 | null | 39.2 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,605 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.001 |
MTT
|
TetrazoliumSalt
| 96.37 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,606 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.01 |
MTT
|
TetrazoliumSalt
| 95.05 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,607 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.1 |
MTT
|
TetrazoliumSalt
| 97.69 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,608 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 1 |
MTT
|
TetrazoliumSalt
| 99.67 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,609 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 5 |
MTT
|
TetrazoliumSalt
| 95.38 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,610 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 10 |
MTT
|
TetrazoliumSalt
| 96.37 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,611 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 20 |
MTT
|
TetrazoliumSalt
| 94.719 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,612 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 50 |
MTT
|
TetrazoliumSalt
| 97.03 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,613 |
Al2O3
|
Sphere
| null |
Commercial
|
Positive
| 267 | 36.3 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 100 |
MTT
|
TetrazoliumSalt
| 91.749 |
10.1007/s10565-011-9191-9
| 82 | null | 39.7 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,614 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.001 |
MTT
|
TetrazoliumSalt
| 98.02 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,615 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.01 |
MTT
|
TetrazoliumSalt
| 95.71 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,616 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.1 |
MTT
|
TetrazoliumSalt
| 96.04 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,617 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 1 |
MTT
|
TetrazoliumSalt
| 99.01 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,618 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 5 |
MTT
|
TetrazoliumSalt
| 82.838 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,619 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 10 |
MTT
|
TetrazoliumSalt
| 63.366 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,620 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 20 |
MTT
|
TetrazoliumSalt
| 45.215 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,621 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 50 |
MTT
|
TetrazoliumSalt
| 16.172 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,622 |
CuO
|
Sphere
| null |
Commercial
|
Positive
| 239 | 42.8 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 100 |
MTT
|
TetrazoliumSalt
| 14.191 |
10.1007/s10565-011-9191-9
| 82 | null | 46.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,623 |
ZnO
|
Sphere
| null |
Commercial
|
Positive
| 310 | 32.7 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.001 |
MTT
|
TetrazoliumSalt
| 95.724 |
10.1007/s10565-011-9191-9
| 82 | null | 45.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,624 |
ZnO
|
Sphere
| null |
Commercial
|
Positive
| 310 | 32.7 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.01 |
MTT
|
TetrazoliumSalt
| 97.368 |
10.1007/s10565-011-9191-9
| 82 | null | 45.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,625 |
ZnO
|
Sphere
| null |
Commercial
|
Positive
| 310 | 32.7 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 0.1 |
MTT
|
TetrazoliumSalt
| 100.33 |
10.1007/s10565-011-9191-9
| 82 | null | 45.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,626 |
ZnO
|
Sphere
| null |
Commercial
|
Positive
| 310 | 32.7 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 1 |
MTT
|
TetrazoliumSalt
| 98.355 |
10.1007/s10565-011-9191-9
| 82 | null | 45.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,627 |
ZnO
|
Sphere
| null |
Commercial
|
Positive
| 310 | 32.7 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 5 |
MTT
|
TetrazoliumSalt
| 91.776 |
10.1007/s10565-011-9191-9
| 82 | null | 45.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,628 |
ZnO
|
Sphere
| null |
Commercial
|
Positive
| 310 | 32.7 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 10 |
MTT
|
TetrazoliumSalt
| 75 |
10.1007/s10565-011-9191-9
| 82 | null | 45.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
2,629 |
ZnO
|
Sphere
| null |
Commercial
|
Positive
| 310 | 32.7 | 50,000 |
H
|
Human
|
Heart
|
Epithelial
|
Adult
| 12 | 20 |
MTT
|
TetrazoliumSalt
| 63.816 |
10.1007/s10565-011-9191-9
| 82 | null | 45.3 | null |
HCMEC
|
Cell Biology and Toxicology
|
Springer Science and Business Media LLC
| 2,011 |
Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells
| false |
FALSE
|
closed
|
82_sun2011.pdf
| 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.